Short Course Terlipressin for Control of Acute Variceal Bleeding

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

August 31, 2008

Conditions
HemorrhageEsophageal VaricesPortal Hypertension
Interventions
DRUG

Terlipressin

2 mg Terlipressin stat, then 1 mg q6h for total of 72 hours

DRUG

Terlipressin & then Dummy

2 mg Terlipressin stat then 1 mg q6 hours for 24 hours, then a Dummy of Terlipressin q6 hours for the next 48 hours.

Trial Locations (1)

74800

The Aga Khan University Hospital, Karachi

Sponsors
All Listed Sponsors
collaborator

Ferozsons Laboratories Ltd.

INDUSTRY

lead

Aga Khan University

OTHER

NCT00369694 - Short Course Terlipressin for Control of Acute Variceal Bleeding | Biotech Hunter | Biotech Hunter